Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Torsten P. M. Scheithauer, Elena Rampanelli, Max Nieuwdorp, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 457

Showing 1-25 of 457 citing articles:

The gut microbiome as a modulator of healthy ageing
Tarini Shankar Ghosh, Fergus Shanahan, Paul W. O’Toole
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 9, pp. 565-584
Open Access | Times Cited: 428
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405
Intestinal Barrier in Human Health and Disease
Natalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 23, pp. 12836-12836
Open Access | Times Cited: 324
Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
Hangyu Li, Dan-Dan Zhou, Ren‐You Gan, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3211-3211
Open Access | Times Cited: 280
Ultra-processed foods and human health: from epidemiological evidence to mechanistic insights
Bernard Srour, Melissa C. Kordahi, Erica Bonazzi, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 12, pp. 1128-1140
Closed Access | Times Cited: 188
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Zheng Zhou, Bao Sun, Dongsheng Yu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 186
A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut
Sidharth Mishra, Bo Wang, Shalini Jain, et al.
Gut (2023) Vol. 72, Iss. 10, pp. 1848-1865
Open Access | Times Cited: 120
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
Carmine Zoccali, Francesca Mallamaci, Marcin Adamczak, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2017-2032
Open Access | Times Cited: 115
Gut microbiota in the pathogenesis and therapeutic approaches of diabetes
Lucilla Crudele, Raffaella Maria Gadaleta, Marica Cariello, et al.
EBioMedicine (2023) Vol. 97, pp. 104821-104821
Open Access | Times Cited: 92
Role of C-Reactive Protein in Diabetic Inflammation
Julijana Stanimirović, Jelena Radovanović, Katarina Banjac, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 86
Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation
Dalia M. Kopustinskienė, Rūta Masteiková, Robertas Lažauskas, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 660-660
Open Access | Times Cited: 78
Dietary Recommendations for Post-COVID-19 Syndrome
Luigi Barrea, William B. Grant, Evelyn Frías-Toral, et al.
Nutrients (2022) Vol. 14, Iss. 6, pp. 1305-1305
Open Access | Times Cited: 70
Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities
Miguel Á. Ortega, Miguel Ángel Alvarez-Mon, Cielo García‐Montero, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2645-2673
Open Access | Times Cited: 70
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
Daniela Baracaldo-Santamaría, Daniel Felipe Ariza-Salamanca, María Gabriela Corrales-Hernández, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 152-152
Open Access | Times Cited: 69
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Jiaqiang Wu, Kangping Yang, Hancheng Fan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 63
Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease
Melvin R. Hayden
Medicina (2023) Vol. 59, Iss. 3, pp. 561-561
Open Access | Times Cited: 52
Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study
Mingli Luo, Jiahao Cai, Shulu Luo, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 47
Tryptophan Metabolism and Gut Microbiota: A Novel Regulatory Axis Integrating the Microbiome, Immunity, and Cancer
Yingjian Hou, Jing Li, Shuhuan Ying
Metabolites (2023) Vol. 13, Iss. 11, pp. 1166-1166
Open Access | Times Cited: 47
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 46
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 45
Meta-analysis reveals obesity associated gut microbial alteration patterns and reproducible contributors of functional shift
Deep Chanda, Debojyoti De
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 22
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Qichen Long, Fengming Luo, Binghui Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 20
Outer Membrane Vesicles Released from Garlic Exosome‐like Nanoparticles (GaELNs) Train Gut Bacteria that Reverses Type 2 Diabetes via the Gut‐Brain Axis
Kumaran Sundaram, Yun Teng, Jingyao Mu, et al.
Small (2024) Vol. 20, Iss. 20
Open Access | Times Cited: 19
Research advance about plant polysaccharide prebiotics, benefit for probiotics on gut homeostasis modulation
Xiaoqi Liu, Shengpeng Su, Jiaying Yao, et al.
Food Bioscience (2024) Vol. 59, pp. 103831-103831
Closed Access | Times Cited: 19
Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions
Victory Jesutoyosi Ashonibare, Bolaji A. Akorede, P. J. Ashonibare, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top